Table 2: Univariate analysis of prognostic values of 386 patients staged at T3/T4.

AJCC 7th staging 5-year
OS
5-year
LRFS
5-year
DMFS
5-year
DFS
%P%P%P%P

N0T3 (12)91.70.6581000.32491.70.75191.70.457
T4 (51)84.19287.582
N1T3 (20)1000.0471000.1831000.0621000.014
T4 (90)75.289.283.571.5
N2T3 (21)85.20.909810.002950.223810.76
T4 (92)80.497.783.276.2
N3T3 (6)62.50.8171000.63466.70.91666.70.821
T4 (54)59.795.965.955.6
ALL T3 (59)89.60.10593.60.66793.20.03588.10.033
ALL T4 (287)75.593.280.872.8

OS, overall survival; LRFS, local relapse-free survival; DMFS, distant metastasis-free survival; DFS, disease-free survival.